Dr. Alex Giaquinto Joins Biothera Board of Directors
EAGAN, MN — June 9, 2008 — Alex Giaquinto, Ph.D., a former Schering-Plough senior executive, has joined the Biothera Board of Directors, the company announced today. Biothera is a biotechnology company developing pharmaceuticals and functional food ingredients based on a unique technology that engages and directs the innate immune system.
Dr. Giaquinto’s extensive pharmaceutical industry experience includes positions as Senior Vice President of Worldwide Regulatory Affairs at Schering-Plough Research Institute and the Senior Vice President of Global Compliance at Schering-Plough Corporation. He also has held numerous professional and academic positions, including Chairman of the Regulatory Affairs Coordinating Committee of the Pharmaceutical Research and Manufacturers Association, a lecturer on drug law at Temple University, and advisor to the University of Texas regarding its International Conference for Drug Development. Dr. Giaquinto is currently a special advisor to Tunnell Consulting, an integrative consulting company focused on life sciences.
“Alex Giaquinto’s tremendous pharmaceutical experience and expertise will help guide Biothera’s efforts to bring Imprime PGG® through the FDA regulatory approval process,” said Daniel Conners, Biothera Chairman and Founder.
Biothera is currently conducting a clinical trial in metastatic colorectal cancer patients with a combination of Imprime PGG, Erbitux® (cetuximab) and Comptosar (irinotecan). A trial in lung cancer patients receiving Imprime PGG, Avastin® (bevacizumab) and two chemotherapy drugs — Taxol (paclitaxel) and Paraplatin (carboplatin) — is expected to begin in the second quarter of 2008.
Dr. Giaquinto received a doctorate in Pharmaceutics from the University of Connecticut and a bachelor’s degree in Pharmacy from the St. John’s University College of Pharmacy.
About Biothera, the Immune Health Company
Biothera is a biotechnology company dedicated to improving immune health. The company is developing pharmaceuticals that engage the innate immune system to fight cancer. Biothera also manufactures and markets Wellmune WGP® and other food-grade ingredients that support healthy immune function to the nutritional supplement, functional food, cosmetic and animal nutrition markets.
Contact:
David Walsh
VP Communications
Biothera, the Immune Health Company
651-256-4606 (direct)